France · Delayed Price · Currency is EUR Vetoquinol Statistics
Total Valuation
Vetoquinol has a market cap or net worth of EUR 899.55 million. The enterprise value is 693.83 million.
| Market Cap | 899.55M |
| Enterprise Value | 693.83M |
Important Dates
The last earnings date was Friday, September 11, 2026.
| Earnings Date | Sep 11, 2026 |
| Ex-Dividend Date | Jun 3, 2026 |
Share Statistics
Vetoquinol has 11.62 million shares outstanding.
| Current Share Class | 11.62M |
| Shares Outstanding | 11.62M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 4.08% |
| Owned by Institutions (%) | 9.21% |
| Float | 3.65M |
Valuation Ratios
The trailing PE ratio is 14.33 and the forward PE ratio is 14.10.
| PE Ratio | 14.33 |
| Forward PE | 14.10 |
| PS Ratio | 1.71 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 11.07 |
| P/OCF Ratio | 9.15 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.08, with an EV/FCF ratio of 8.54.
| EV / Earnings | 11.06 |
| EV / Sales | 1.32 |
| EV / EBITDA | 6.08 |
| EV / EBIT | 8.17 |
| EV / FCF | 8.54 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 67.67 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 14.69% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 9.06% |
| Revenue Per Employee | 214,909 |
| Profits Per Employee | 25,575 |
| Employee Count | 2,486 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Vetoquinol has paid 24.74 million in taxes.
| Income Tax | 24.74M |
| Effective Tax Rate | 28.28% |
Stock Price Statistics
The stock price has increased by +6.91% in the last 52 weeks. The beta is 0.87, so Vetoquinol's price volatility has been lower than the market average.
| Beta (5Y) | 0.87 |
| 52-Week Price Change | +6.91% |
| 50-Day Moving Average | 71.13 |
| 200-Day Moving Average | 76.76 |
| Relative Strength Index (RSI) | 70.35 |
| Average Volume (20 Days) | 9,090 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vetoquinol had revenue of EUR 527.39 million and earned 62.76 million in profits.
| Revenue | 527.39M |
| Gross Profit | 312.46M |
| Operating Income | 84.93M |
| Pretax Income | 87.48M |
| Net Income | 62.76M |
| EBITDA | 107.94M |
| EBIT | 84.93M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | n/a |
| Book Value Per Share | n/a |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 98.28 million and capital expenditures -17.02 million, giving a free cash flow of 81.25 million.
| Operating Cash Flow | 98.28M |
| Capital Expenditures | -17.02M |
| Depreciation & Amortization | 23.01M |
| Net Borrowing | 1.05M |
| Free Cash Flow | 81.25M |
| FCF Per Share | 6.99 |
Margins
Gross margin is 59.25%, with operating and profit margins of 16.10% and 11.90%.
| Gross Margin | 59.25% |
| Operating Margin | 16.10% |
| Pretax Margin | 16.59% |
| Profit Margin | 11.90% |
| EBITDA Margin | 20.47% |
| EBIT Margin | 16.10% |
| FCF Margin | 15.41% |
Dividends & Yields
This stock pays an annual dividend of 0.93, which amounts to a dividend yield of 1.33%.
| Dividend Per Share | 0.93 |
| Dividend Yield | 1.33% |
| Dividend Growth (YoY) | 4.49% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 16.57% |
| Buyback Yield | n/a |
| Shareholder Yield | 1.33% |
| Earnings Yield | 6.98% |
| FCF Yield | 9.03% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for Vetoquinol is 91.50, which is 18.22% higher than the current price. The consensus rating is "Buy".
| Price Target | 91.50 |
| Price Target Difference | 18.22% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 2.92% |
| EPS Growth Forecast (3Y) | 6.90% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |